MARKET

OTLKW

Outlook Therapeutics Inc
OTLKW
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-0.2941
0.0670
1.149
-
Outlook Therapeutics Inc. Announces Date for Upcoming Annual Stockholders Meeting
Reuters · 01/26 22:02
Outlook Therapeutics Appoints Laura Cantrell as Vice President of Corporate Strategy and Business Development
Reuters · 01/06 13:35
BUZZ-U.S. STOCKS ON THE MOVE-Ulta Beauty and Berkshire Hathaway
Reuters · 01/02 18:42
BUZZ-Outlook Therapeutics plunges after FDA rejects eye drug for third time
Reuters · 01/02 11:13
OUTLOOK THERAPEUTICS SHARES PLUNGE 61.5% PREMARKET AFTER US FDA DECLINES TO APPROVE EYE DISEASE DRUG
Reuters · 01/02 09:04
BUZZ-Outlook Therapeutics slides after US FDA declines its eye disease drug
Reuters · 12/31/2025 22:21
OUTLOOK THERAPEUTICS INC: FDA HAS NOT INDICATED WHAT TYPE OF CONFIRMATORY EVIDENCE WOULD BE ACCEPTABLE
Reuters · 12/31/2025 21:15
Outlook Therapeutics Grants Stock Options to New Employees
Reuters · 12/26/2025 22:00
More

Webull offers Outlook Therapeutics Inc stock information, including NASDAQ: OTLKW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OTLKW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OTLKW stock methods without spending real money on the virtual paper trading platform.